These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 19755969

  • 1. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 2. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
    [Abstract] [Full Text] [Related]

  • 3. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
    Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.
    Aliment Pharmacol Ther; 2008 Nov 15; 28(10):1221-9. PubMed ID: 18752630
    [Abstract] [Full Text] [Related]

  • 4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 15; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 5. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.
    Eur J Gastroenterol Hepatol; 2010 Mar 15; 22(3):340-5. PubMed ID: 19581809
    [Abstract] [Full Text] [Related]

  • 6. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF.
    QJM; 2005 Jun 15; 98(6):435-41. PubMed ID: 15879440
    [Abstract] [Full Text] [Related]

  • 7. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB, Brandse JF, van Wilpe S, Löwenberg M, Ponsioen C, van den Brink G, D'Haens G.
    Scand J Gastroenterol; 2015 Jul 15; 50(7):841-7. PubMed ID: 25636819
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG, Nieminen U, Turunen U, Arkkila P, Sipponen T, Färkkilä M.
    Scand J Gastroenterol; 2012 May 15; 47(5):528-37. PubMed ID: 22356594
    [Abstract] [Full Text] [Related]

  • 11. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
    Schaffer T, Schoepfer AM, Seibold F, Swiss IBD Cohort Study Group.
    J Crohns Colitis; 2014 Sep 15; 8(9):1125-32. PubMed ID: 24636141
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group.
    Scand J Gastroenterol; 2011 Sep 15; 46(9):1081-91. PubMed ID: 21619483
    [Abstract] [Full Text] [Related]

  • 13. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T, López-García A, Rodríguez-Moranta F, Ruiz A, Rodríguez L, Guardiola J.
    J Crohns Colitis; 2013 Dec 15; 7(12):e641-51. PubMed ID: 23810085
    [Abstract] [Full Text] [Related]

  • 14. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
    Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL.
    Scand J Gastroenterol; 2010 Mar 15; 45(3):325-31. PubMed ID: 20034360
    [Abstract] [Full Text] [Related]

  • 15. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Bertin E, Luise A, Frego M, Plebani M, Sturniolo GC, D'Amico DF, Angriman I.
    Dis Colon Rectum; 2007 Jun 15; 50(6):861-9. PubMed ID: 17473939
    [Abstract] [Full Text] [Related]

  • 16. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, Gearry RB.
    Gastroenterology; 2015 May 15; 148(5):938-947.e1. PubMed ID: 25620670
    [Abstract] [Full Text] [Related]

  • 17. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
    Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M.
    Scand J Gastroenterol; 2012 Jul 15; 47(7):778-84. PubMed ID: 22519419
    [Abstract] [Full Text] [Related]

  • 18. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML.
    BMC Gastroenterol; 2020 Feb 13; 20(1):35. PubMed ID: 32054445
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct 13; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.